Cargando…
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
Immune checkpoint inhibitors, such as pembrolizumab, are revolutionizing therapeutic strategies for different cancer types, including non‐small‐cell lung cancer (NSCLC). However, only a subset of patients benefits from this therapy, and new biomarkers are needed to select better candidates. In this...
Autores principales: | Mondelo‐Macía, Patricia, García‐González, Jorge, León‐Mateos, Luis, Anido, Urbano, Aguín, Santiago, Abdulkader, Ihab, Sánchez‐Ares, María, Abalo, Alicia, Rodríguez‐Casanova, Aitor, Díaz‐Lagares, Ángel, Lago‐Lestón, Ramón Manuel, Muinelo‐Romay, Laura, López‐López, Rafael, Díaz‐Peña, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564635/ https://www.ncbi.nlm.nih.gov/pubmed/34465006 http://dx.doi.org/10.1002/1878-0261.13094 |
Ejemplares similares
-
Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022) -
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020) -
Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016) -
Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
por: Muinelo-Romay, Laura, et al.
Publicado: (2014) -
Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer
por: Rodríguez-Casanova, Aitor, et al.
Publicado: (2021)